Showing results (31-40 of 212) with videos related to
Sort By:
Pageof 22
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibodies for molecular imaging of cancerAnna M Wu, Tove OlafsenBioconjugate Chemistry|September 18, 2003
Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugatesCraig Beeson, James E Butrynski, Michael J Hart, et al.Biomolecular Engineering|March 24, 2007
Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulumBhaswati Barat, Anna M WuBioconjugate Chemistry|September 23, 2008
Novel peptide linkers for highly potent antibody-auristatin conjugateSvetlana O Doronina, Tim D Bovee, David W Meyer, et al.Bioconjugate Chemistry|September 18, 2003
Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineeringCharlotte F McDonagh, Kevin S Beam, Gabrielle J S Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigenDangshe Ma, Christine E Hopf, Andrew D Malewicz, et al.Bioorganic & Medicinal Chemistry Letters|April 24, 2009
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker systemPatrick J Burke, Brian E Toki, David W Meyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.Molecular Immunology|May 3, 2015
In vivo imaging with antibodies and engineered fragmentsAmanda C Freise, Anna M WuPageof 22